Universal DX
Business Services · Spain · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10 Avenida Diego Martínez Barrio Edifici...Phone Number
+34 674945571Website
www.universaldx.comRevenue
$5.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Universal DX
Universal DX is focused on developing innovative blood tests for the early detection of cancer, aiming to transform it into a preventable and curable disease. Their flagship product, Signal-C, is a liquid biopsy test that accurately detects colorectal cancer and advanced adenomas with high sensitivity and specificity. The company collaborates strategically with Quest Diagnostics to enhance the accessibility of their tests, thereby aiming to reduce colorectal cancer incidence and mortality in the U.S. population. With a commitment to scientific advancement, Universal DX actively participates in prestigious conferences to share their findings and engage with the clinical community.Explore more
Universal DX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Universal DX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Universal DX recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Universal DX has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Universal DX launches new products
Click to see if Universal DX had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Universal DX has new funding data
Congratulate Masked Content for being promoted to Masked Content at Universal DX
Check out if Universal DX is spiking on competitors!
Universal DX, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Universal DX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Universal DX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Universal DX.
Universal DX Tech Stack
A closer look at the technologies used by Universal DX
Most Recent Scoops
Open Position
Hiring Plans
Universal DX has more open roles in Information Technology than it has had at any time in the past 12 months with an increased focus on technologies like Netskope, and experience with Smartsheet, and macOS.
Hiring Plans
Hiring Plans
Universal DX has more open roles in Engineering & Technical than it has had at any time in the past 12 months with an increased focus on technologies like macOS, and Netskope. Additionally the postings have an increased focus on skills like Endpoint Management, Cloud Security Infrastructure, Risk Reduction, and Netskope, and experience with Quality Management Reviews, Validation Testing, and Software Development Life Cycle.
Hiring Plans
Open Position
Open Position
Universal DX News & Media
Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced ...
UDX also announces the initial closing of its series B financing of approximately $70 million with investors, including Quest Diagnostics Financing to support UDX's pursuit of FDA premarket...Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
UDX also announces the initial closing of its series B financing of approximately $70 million with investors, including Quest Diagnostics Financing to support UDX's pursuit of FDA premarket approval for its colorectal cancer screening blood test CAMBRDIGE, Mass. and SECAUCUS, N.J., Nov....CORRECTING and REPLACING Universal DX Presents Data from Large, 1,000-patient, Multi-Cohort Study Proving 93% Sensitivity for Colorectal Cancer and 54% Sensitivity for Advanced Adenoma at 92% Specificity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Headline and first paragraph of release, colorectal cancer sensitivity percent should read: 93% (instead of 91%). The updated release reads: UNIVERSAL DX PRESENTS DATA FROM LARGE, 1,000-PATIENT, MULTI-COHORT STUDY PROVING 93% SENSITIVITY FOR COLORECTAL CANCER AND 54% SENSITIVITY FOR ADVANCED ADENOMA AT 92% SPECIFICITY Findings highlight company’s approach is highly accurate for early-stage (I-II) detection: CRCs (91% sensitivity) and AA (54% sensitivity) at 92Universal DX Presents Data from Large, 1,000-patient, Multi-Cohort Study Proving 91% Sensitivity for Colorectal Cancer and 54% Sensitivity for Advanced Adenoma at 92% Specificity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results of a large international multi-cohort case-control study, which demonstrate that cell-free DNA methylation and fragmentation signals combined with machine-learning can be used to detect early-stage colorectal cancer (CRC) with 91% and pre-cancerous advanced adenomas (AA) with 54% sensitivity at 92%
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Universal DX
Sign Up For FreeTo access detailed company insights
Universal DX is focused on developing innovative blood tests for the early detection of cancer, aiming to transform it into a preventable and curable disease. Their flagship product, Signal-C, is a liquid biopsy test that accurately detects colorectal cancer and advanced adenomas with high sensitivity and specificity. The company collaborates strat... Read More
